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Automatic quantitative analysis of experimental primary and
secondary retinal neurodegeneration: implications for optic
neuropathies
BM Davis1, L Guo1, J Brenton1, L Langley1, EM Normando2 and MF Cordeiro1,2
Secondary neurodegeneration is thought to play an important role in the pathology of neurodegenerative disease, which potential
therapies may target. However, the quantitative assessment of the degree of secondary neurodegeneration is difﬁcult. The present
study describes a novel algorithm from which estimates of primary and secondary degeneration are computed using well-
established rodent models of partial optic nerve transection (pONT) and ocular hypertension (OHT). Brn3-labelled retinal ganglion
cells (RGCs) were identiﬁed in whole-retinal mounts from which RGC density, nearest neighbour distances and regularity indices
were determined. The spatial distribution and rate of RGC loss were assessed and the percentage of primary and secondary
degeneration in each non-overlapping segment was calculated. Mean RGC number (82 592 ± 681) and RGC density (1695 ± 23.3
RGC/mm2) in naïve eyes were comparable with previous studies, with an average decline in RGC density of 71 ± 17 and 23± 5%
over the time course of pONT and OHT models, respectively. Spatial analysis revealed greatest RGC loss in the superior and central
retina in pONT, but signiﬁcant RGC loss in the inferior retina from 3 days post model induction. In comparison, there was no
signiﬁcant difference between superior and inferior retina after OHT induction, and RGC loss occurred mainly along the superior/
inferior axis (~30%) versus the nasal–temporal axis (~15%). Intriguingly, a signiﬁcant loss of RGCs was also observed in contralateral
eyes in experimental OHT. In conclusion, a novel algorithm to automatically segment Brn3a-labelled retinal whole-mounts into non-
overlapping segments is described, which enables automated spatial and temporal segmentation of RGCs, revealing heterogeneity
in the spatial distribution of primary and secondary degenerative processes. This method provides an attractive means to rapidly
determine the efﬁcacy of neuroprotective therapies with implications for any neurodegenerative disorder affecting the retina.
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INTRODUCTION
Secondary neurodegeneration is reported to play a signiﬁcant role
in many diseases of growing socioeconomic and health-economic
concern, including neurodegenerative diseases, spinal cord
injuries and optic neuropathies.1–7 It is thought to occur through
a combination of excitotoxicity, inﬂammation and oxidative stress
pathways, which provide attractive therapeutic targets as
secondary neurodegeneration is clinically more modiﬁable than
primary.8–10 Although substantial progress has been made in our
understanding of these disorders in recent years, including
recognition of similarities between these conditions,11,12 there
are presently few effective disease-modifying therapies to slow or
reverse the course of neurodegeneration.
One of the most common ophthalmic neurodegenerative
diseases is glaucoma, which comprises a distinctive group of
progressive optic neuropathies and is the leading cause of
irreversible blindness globally.13 Gradual degeneration of RGCs
and optic nerve damage, with characteristic changes in appear-
ance of the optic disc, is responsible for the progressive visual ﬁeld
loss. Classically (but not exclusively), this manifests as an initial
permanent loss of peripheral vision, leading to central vision
defects as the disease progresses.14,15 Presently, there is no
curative treatment for glaucoma, with existing therapies targeting
raised intraocular pressure (IOP), the major and modiﬁable risk
factor.16,17 Glaucoma is a complex and multifactorial disease, with
variation in disease progression, and vision loss continuing to
occur in some patients, despite well-controlled IOPs,18 suggesting
that secondary RGC degeneration plays an important role in
glaucoma pathology.10,19
Rodent models of glaucoma have proven essential in under-
standing disease progression and assessing efﬁcacy of therapeutic
interventions. In this respect, quantitative assessment of RGC loss
is a commonly used end point to assess experimental glaucoma-
tous degeneration and therapeutic intervention efﬁcacy.10,20
Although none are exact models of human disease, they allow
study of different mechanistic aspects.21 Partial optic nerve
transection (pONT) is a useful model ﬁrst described in cynomolgus
monkeys and Wistar rats.7,22 This model facilitates segregation of
primary and secondary degeneration processes by transecting
only the superior optic nerve, enabling mechanisms of RGC
degeneration and efﬁcacy of therapeutic interventions to be
assessed.10,23,24 Another, well-established rodent model of glau-
coma is the Morrison model of ocular hypertension (OHT), which
involves injection of hypertonic saline into the episcleral veins to
induce elevated IOP via induction of sclerosis of the trabecular
meshwork impeding aqueous drainage.25 The resulting elevated
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IOP is correlated with increased RGC apoptosis26,27 and functional
assessment of RGC loss suggests moderate sustained elevation of
IOP results in peripheral vision loss.28
Brn3a is a POU-domain transcription factor considered a good
histological RGC marker, due to its high RGC speciﬁcity and
good agreement with retrograde axonal tracer Fluoro-Gold (97%
RGC co-labelling in rats).29 As Brn3a is localised to RGC nuclei,
immunohistochemistry of retinal whole-mounts yields images from
which RGCs can be readily segmented (Figure 1a). Quantiﬁcation
of Brn3a RGCs is frequently obtained by manually counting
retinal segments;7,30–33 yet a limitation of this approach is the high
variability in RGC density between central and peripheral rodent
retina, which can complicate RGC quantiﬁcation by sampling.34 To
address these concerns, whole retinas need to be assessed and
several groups, including our own, have developed tools to
automatically count Brn3a-labelled RGCs, results of which are most
frequently presented quantitatively as average whole-mount RGC
density (RGC/mm2) or qualitatively as isodensity maps.10,29,35,36
In this study we describe a new segmentation algorithm
for automatic determination of regional RGC density, nearest
neighbour distance (NND) and regularity index (RI), using a series
of 15 concentric rings centred on the optic nerve head (ONH),
segmented into quadrants. We apply this method to investigate
the patterns and natural history of RGC loss in two well-
established models of glaucoma: the Morrison’s model of OHT25
and pONT,23 to assess primary and secondary neuronal degen-
erative processes as potential therapeutic targets.
RESULTS
Establishment of a novel algorithm for whole-retinal RGC analysis
and spatial segmentation
Using the previously established automated RGC counting
algorithm,10 a method was established to spatially segment
Brn3a-labelled retinal whole-mounts. This enabled the spatial and
temporal distribution of RGC loss to be automatically determined
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Figure 1. Diagram of RGC segmentation and counting used in this study. (a) Identiﬁcation of RGC number, area and centroid from Brn3a-
labelled retinal whole-mounts was completed using previously described methods.10 (b) Retinal area was determined by ﬁrst creating a binary
mask of the whole-mount area before applying a customised ImageJ script to measure the retinal area (black pixels) in each retinal segment
(ring and quadrants). (c) On deﬁning the centre of the ONH, a series of 15 concentric rings with 0.3 mm radii were drawn and the position of
each RGC determined by calculating the Euclidean distance [D] of each RGC relative to the ONH using ring boundaries as thresholds. RGCs
were further segmented into quadrants (d and e) (where m= b/a) deﬁned using Cartesian (d) or polar coordinates (e) which gave identical
results. For each segment, in each case RGC density, average nearest neighbour distance and regularity index were calculated as described in
the text.
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(Figure 1). This script was initially used to evaluate a series of
control eyes: average retinal area (52.4 ± 5.1 μm), Brn3a positive
RGC number (82 592± 681 RGCs/retina) and average whole-retinal
RGC density (1695 ± 23.3 RGC/mm2) were documented.
Established retinal neuronal mosaic parameters include NNDs
and Regularity Indices (RIs). NND refers to the distance between
each neuron and its nearest neighbour in the mosaic, presented as
the mean NND.37 RI presents one of the most popular methods for
quantifying retinal mosaics and comprises a spatial statistic
derived from the frequency distribution of NNDs, and is calculated
by dividing the mean NND by the standard deviation of the NDD
of a population within a sample ﬁeld (equation (1)).38 As orderly
retinal mosaics possess an approximate Gaussian NND frequency
distribution and random retinal mosaics possess a Poisson distribu-
tion, greater RI ratios will be observed for Gaussian (ordered)
distributions of retinal cells.39 Typically, the RI for neurons arranged
randomly is 1.9, and the more regular the arrangement, the higher
the RI.37 The RI for retinal mosaics observed to date, is reported to be
between 3 and 8.38 However, the exact threshold for determining
whether the mosaic is non-randomly arranged depends on the
number of neurons and the geometry of the ﬁeld. In addition, the
physical size of soma may introduce lower limits (an exclusion radius)
onto NNDs which may adversely inﬂuence RI calculations.37 For
control DA rat retina, an average RI of 2.86±0.03 was obtained,
which is indicative of a retinal mosaic with a regular arrangement.37
Application of the whole-retinal algorithm for the spatial and
temporal assessment of the RGC mosaic in rodent models of optic
neuropathy
To spatially segment retinal RGC populations, the centroid of each
Brn3a-labelled RGC was next used to calculate its position relative to
the ONH using vector coordinates, before a series of 15 concentric
rings subdivided into four quadrants were constructed from which
regional RGC density, NND and RI parameters were determined
(Figures 1c–e). This RGC segmentation algorithm was applied to
a total of 83 whole-mounted Brn3a-labelled retina 3, 7, 21 and
56 days after pONT induction or 7, 21, 56 and 84 days post OHT
induction. A signiﬁcant reduction in RGC density was observed from
3 days of pONT model induction and after 7 days of OHT model
induction, and RGC density declined by 71 ± 11 and 23 ± 5% over
the course of pONT and OHT models, respectively, compared with
a population of naïve eyes (Table 1). Upon completion of RGC
segmentation, NNDs were computed from each Brn3a positive
RGC, and combined with RGC centroid data to produce qualitative
NND colour maps (Figure 2a), where the smallest NNDs (red)
represent regions of greatest RGC density, larger NNDs (green/blue)
regions of low RGC density. Quantitative analysis of normalised
NND distributions (Figures 2b–i) reveals that over the course of pONT
and OHT models, overall NND distribution shifted to greater values,
suggestive of diffuse RGC loss (primary degeneration).40,41 The
concurrent increase in skew of the NND distribution to higher
NND values (Figures 2b–e) versus naive controls is evidence of an
additional component of clustered RGC loss, which may be
indicative of secondary degenerative processes.40,41
RGCs loss occurs predominantly in the superior-central retinal in
the pONT model
We next analysed the pattern of RGC loss in the pONT model and
its progression over time (Figure 3a). A signiﬁcant loss of RGC
density occurs rapidly from 3 days after model induction which
plateaus by 56 days (Po0.001; Table 1). This effect is mirrored by
a delayed but signiﬁcant increase in RGC NND (Figure 3b) from
baseline to 7 days post pONT induction (14.42 ± 0.08 versus
16.88 ± 0.75 μm, Po0.05). RI appears initially insensitive to pONT
model induction (3 days post pONT) but as the model progresses,
from 7 days onwards (2.55 ± 0.09, Po0.01), RI values begin to
decline (Figure 3c). By 21 days post pONT induction, RI approaches T
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1.9 which is indicative of a retinal mosaic comprising randomly
distributed RGCs.37 Further segmentation of the pONT retinal whole-
mounts into quadrants (Figures 3d–f) reveals that signiﬁcantly greater
loss of RGC density was observed in the superior quadrant (Figure 3d,
Po0.001) at 21 and 56 days post model induction. This pattern of
RGC loss was reﬂected in signiﬁcant differences in NND (Figure 3e,
Po0.01) and RI values (Figure 3f, Po0.01 and Po0.05 for 21 and
56 days, respectively). Further segmentation of superior and inferior
retinal quadrants into 15 concentric rings suggests that RGC loss in
both superior and inferior sectors progresses quickly after pONT
model induction and is primarily concentrated in the central superior
retina.
RGC loss predominantly occurs along the superior–inferior axis in
the OHT model
The decline in RGC density observed in the Morrison’s OHT model
was less than that observed in the pONT model (Figure 4a and
Table 1). IOP peaked 24h post OHT model induction with an
average IOP of 19.9 ± 3.2 versus 12.0 ± 4.0 mm Hg in untreated
contralateral eyes. A signiﬁcant increase in IOP was observed in all
OHT eyes (Po0.05) versus untreated contralateral eyes, similar to
those previously reported by our group.42 A signiﬁcant loss of RGC
density was observed from 7 days post OHT induction (Figures 4a,
Po0.001), which was accompanied by signiﬁcant increases in NND
(Figure 4b) from 21 days (14.42 ±0.08 versus 15.71 ±0.28 μm for
control and 21 days post OHT model induction). RI exhibited only
a mild decline over the course of this model (Figure 4c), only
achieving signiﬁcance at 84 days post OHT induction (2.86±0.03
versus 2.55±0.11, Po0.05 for controls and 84 days post OHT model
induction, respectively), suggesting retinal mosaic regularity was
largely preserved, likely due to the relatively mild IOP elevation in
this model.
Segmentation of the OHT retinal whole-mounts into quadrants
(Figures 4d–f) reveals that RGC loss occurs at a similar rate
throughout the entire retina, with no signiﬁcant difference in RGC
density (Figure 4d), NND (Figure 4e) or RI (Figure 4f) in superior
and inferior quadrants at any time point investigated. Further
segmentation of superior and inferior quadrants into 15 con-
centric rings reveals that RGC density declines more rapidly in the
retinal centre than in the periphery (Figure 4g). This observation is
mirrored by more pronounced increases in NND and declines in RI
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Figure 2. Change in NND distribution over the course of pONT and OHT models. (a) Colour maps comparing changes in RGC nearest
neighbour distance in pONT and OHT models over time, scale bar = 2 mm. (b–e) Longitudinal changes in global NND distribution over the
course of the pONT (b and c) and OHT (d and e) models (red) versus naïve controls (black). (f–i) Graphs illustrating the proportion of the
normalised NND distribution with NNDs (b and c) greater than 20 μm (f and h) and 40 μm (g and i) in the pONT (f and g) and OHT (h and i)
models. Difference versus naïve controls determined using a one-way ANOVA with Dunns post hoc test.
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in the central retina compared with the retinal periphery over the
course of this model.
Signiﬁcant RGC loss occurs in contralateral eyes in the OHT model
Analysis of contralateral untreated eyes from OHT cohorts was
next performed (Figure 5). A signiﬁcant decline in RGC density
(Figure 5a) was observed from 7 days post OHT induction
(Po0.001) (in an IOP related relationship), but to a lesser extent
than eyes which were subject to elevated IOP (average RGC
density loss 84 days post OHT induction 23± 5% versus 14 ± 6% for
OHT and contralateral eyes, respectively, Table 1). Average NND
increased from 7 days but only reached signiﬁcance (Po0.01)
versus naïve controls 56 days post OHT inductions (14.42 ± 0.18
versus 15.44 ± 0.37, Po0.01; Figure 5b). A similar trend was
observed in RI (2.86 ± 0.03 versus 2.51 ± 0.18, Po0.05; Figure 5c),
suggesting preservation of RGC retinal mosaic. Further segmenta-
tion of retinal whole-mounts into 15 concentric rings (Figure 5d)
reveals that loss of RGC density and NND occurs primarily in the
central retinal and that despite signiﬁcant loss of RGCs, RI remains
largely unaffected, indicating preservation of the retinal mosaic.
Pattern of RGC loss reveals primary and secondary degenerative
changes in OHT model comparable to human optical coherence
tomography retinal nerve ﬁbre layer segmentation
Clinically, optical coherence tomography retinal nerve ﬁbre layer
(RNFL) thickness changes are assessed by quadrant over time.43,44
We next investigated whether quadrant analysis could be used
to deﬁne the rate of RGC density loss. Mean RGC density in each
quadrant ring was plotted over time (Figures 6a and b) and ﬁt to
exponential decay equations (equations (4)–(6)). Results were used
to construct colour maps of percentage RGC density loss and
half-life and to estimate the percentage of primary degeneration
in each ring segment (Figure 6c). Figure 6c illustrates that in the
pONT model, the greatest percentage of RGC density loss
occurred in the superior and central retinal segments (red regions)
and least in the inferior segment and retinal periphery (blue
sectors). This observation broadly correlated with half-life obser-
vations which were generally lower in the superior and central
sectors (t1/2 ~ 4 days, yellow sectors) versus the inferior periphery
sectors (t1/2410 days, green sectors). Interestingly the lowest
half-life of RGC density decay was observed in the central inferior
retina (t1/2 ~ 9 days, orange sectors). By comparison, in the OHT
model, the greatest percentage loss of RGC density was observed
in the superior and inferior retinal sectors (~30% RGC density loss,
red), versus the nasal and temporal quadrants (20–0%, white–blue
sectors). Half-lives of RGC decay in this model were less in the
superior retina than in other sectors, (average t1/2 superior
retina = 2.5 versus 4.7, 9.2 and 7.4 days in the inferior, nasal and
temporal retina, respectively). This pattern of RGC loss is in
agreement with previous observations using axonal sections and
optical coherence tomography in the same rodent model of OHT,
where greater RNFL thinning was observed in the superior–
inferior axis versus the nasal–temporal axis.25,42 RNFL thinning has
been suggested as a risk factor for future visual ﬁeld loss.45 The
pattern of RGC loss observed also closely matches the bowtie-like
pattern of RNFL loss previously reported in human glaucoma
patients46 and is supported by recent clinical observations where
signiﬁcant thinning of the RNFL in the superior and inferior retina
was observed in a population of glaucoma suspects.47
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Figure 3. Retinal ganglion cell (RGC) survival after partial optic nerve transection (pONT) in the DA rat. Whole-retinal proﬁles of pONT induced
loss of (a) RGC density, (b) nearest neighbour distance and (c) regularity index demonstrating signiﬁcant reducing in RGC populations and
retinal mosaic regularity over the course of this model (one-way ANOVA with Dunnets’ post hoc test versus naïve controls). (d–f) Comparison
of RGC survival in the superior versus inferior retinal quadrants after pONT in the DA rat . (d) RGC density, (e) nearest neighbour distance and
(f) regularity index in the superior (white) and inferior (black) retinal quadrants as outlined in Figure 1. RGC loss was signiﬁcantly greater in the
superior retina (paired two-tailed T-test) compared with the inferior retinal quadrant. (g) Further segmentation of RGC populations in the
superior and inferior quadrants into a series of 15 non-overlapping concentric rings centred on the ONH suggest the greatest loss of RGC
density occurs in the superior retinal quadrant versus the inferior quadrant over the course of the pONT model (red) when compared with
naïve controls (black). These observations are reﬂected in the change in NND and RI. Data are presented as means± S.E.
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Finally, to estimate the percentage of primary and secondary
degeneration in each retinal sector, RGC density decay curves
were ﬁt to a two-phase exponential decay model, ﬁxing rates of
RGC loss at t1/2 = 1.7 and 16.3 days for primary and secondary RGC
degeneration as reported previously.48 Figure 6c illustrates that
in the pONT model of retinal degeneration, a combination of
primary and secondary degeneration was observed in the superior
and central retina (65% primary degeneration, green sectors) and
the proportion of primary degeneration declined on approaching
the superior retinal periphery (46% primary degeneration, yellow
sectors). Surprisingly, the greatest occurrence of primary degen-
eration was observed in the central inferior retina, peaking at 84%
in ring 4, while the lowest incidence of primary degeneration
was observed in the interior, nasal and temporal retinal periphery
(20–0%, orange sectors).
DISCUSSION
This study describes a method for segmentation of Brn3a-labelled
retinal whole-mounts to extract greater information regarding the
spatial distribution and rate of RGC loss in the pONT and OHT
models of retinal neurodegeneration than has previously been
achieved (Figure 1). Automated analysis of retinal whole-mounts is
preferable to manual counting of retinal sectors, as it minimises
sampling error, unintentional bias and inter-operator variability.
Using spatial and temporal analysis of RGC loss in these models,
we reveal distinctive patterns of primary and secondary degenera-
tion that correlate with previous observations and RNFL changes in
clinical glaucoma. Finally, signiﬁcant RGC loss was reported in the
contralateral eyes of the OHT model, lending support to the
hypothesis that systemic effects can exacerbate secondary RGC
degeneration in clinical glaucoma.49
Using the algorithm described, naïve retina were found to
possess a comparable number of RGCs and global RGC density as
in previous studies using similar rat species.50,51 Over the course
of the pONT model, RGC density loss was most pronounced in
the superior retina in agreement with previous studies.7,31,48,52
However, in the present study, a signiﬁcant reduction in RGC
density was also observed in the inferior retinal segment as soon
as 3 days post pONT induction, which is much earlier than the
28 days previously reported by Levkovitch-Verbin et al. (Figure 3).
An explanation for this observation is that the Levkovitch-Verbin
study utilised the retrograde Fluorogold labelling rather than
Brn3a, which has previously been reported to provide an earlier
indicator of RGC loss in axonal injury models.50 The observation
that RGC numbers decline rapidly in all regions of the retina after
pONT is in agreement with several recent studies, which report
the rapid spread of oxidative and excitotoxic stress beyond the
initial site of injury and mitochondrial changes within 24h of
model induction.53–55 RGC density loss in both models was found
to ﬁt best to an exponential decay model, in common with
previous studies of rodent ON crush and transection models.52,56
The algorithm uses concentric rings to divide retinal whole-
mounts into a series of 60 non-overlapping sectors, from which
the regional spatial and temporal pattern of RGC loss can be
evaluated. The advantage of this method of analysis, compared
with using a series of concentric circles, is that changes in the
central retina can be effectively differentiated from peripheral
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Figure 4. RGC survival after ocular hypertension (OHT) induction in the DA rat. Whole-retinal proﬁles of OHT induced loss of (a) RGC density,
(b) nearest neighbour distance and (c) regularity index demonstrating signiﬁcant reducing in RGC populations over the course of this model
with only minor degradation in the regularity of the retinal mosaic (one-way ANOVA with Dunnets’ post hoc test versus naïve controls).
(d–f) Comparison of RGC survival in the superior versus inferior retinal quadrants after ocular hypertension (OHT) induction in the DA rat.
Proﬁle of OHT induced loss of (d) RGC density, (e) nearest neighbour distance and (f ) regularity index in the superior (white) and inferior
(black) retinal quadrants as outlined in Figure 1. No signiﬁcant differences in RGC loss were detected between the superior and inferior retinal
segments (paired two-tailed T-test). (g) Further segmentation of RGC populations in the superior and inferior quadrants into a series of 15
non-overlapping concentric rings centred on the ONH suggest that a similar extent of RGC density loss occurs in the superior and inferior
retinal quadrants over the course of this model (red) when compared with naïve controls (black). These observations are reﬂected in the
change in NND and RI. Data are presented as means± S.E.
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Figure 5. Retinal ganglion cell (RGC) survival after contralateral ocular hypertension (OHT) induction in the DA rat. Whole-retinal proﬁle of
(a) RGC density, (b) nearest neighbour distance (NND) and (c) regularity index demonstrating signiﬁcant reducing in RGC populations when
OHT was inducted in the opposite eye (Figure 4) over the course of this model with only minor degradation in the regularity of the retinal
mosaic (one-way ANOVA with Dunnets’ post hoc test versus naïve controls). (d) Segmentation of RGC populations into a series of 15 non-
overlapping concentric rings centred on the ONH suggest that greatest loss of RGC density occurs in the central versus the peripheral retina
over the course of the OHT model (red) when compared with naïve controls (black). These observations are reﬂected in the change in NND
and RI. Data are presented as means± S.E.
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Figure 6. Summary of the rates of RGC loss in retinal segments of the pONT and OHT models. Example proﬁles of RGC density loss in the
central (Ring 4, red) and peripheral (Ring 14, blue) inferior retina form the (a) pONT and (b) OHTmodels ﬁt to a single-phase exponential decay
model (equation (3)). (c) These data were used to construct colour maps summarising the percentage of RGC density loss over the course of
each model, the half-life of RGC loss in each retinal sector on ﬁtting to a single exponential decay model (equation (3)) and estimate the
percentage of primary degeneration on ﬁtting to a two-phase decay model (equations (4)–(6) as described in the text.
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retinal effects, an approach that has previously been used to
eliminate point-pattern bias from Ripley’s K-function.57
Analysis of regional RGC loss revealed that RGC density declined
more substantially in the central retinal sectors than the peripheral
retina in the pONT model (Figures 3 and 6) is in agreement with
previous observations using axotomy models.29 By comparison, RGC
loss in the OHT model was milder than that observed for the pONT
model, reﬂecting the duration (3 weeks) and magnitude of IOP
elevation of the OHT model, in agreement with previous studies.42
RGC loss in this model was concentrated in the central retina (visual
streak). The observation of central retinal defects in both models
of retinal degeneration is in broad agreement with previous studies
using rodent models of OHT and axonal injury.29,58 This is of
particular interest, as it is increasingly recognised that patients with
glaucoma present with more complex retinal-wide visual defects
than solely loss of peripheral vision,59 and coincides with a growing
body of evidence suggesting that early clinical glaucomatous
damage occurs in the macular, the site of greatest RGC density in
humans.60
Secondary degeneration refers to the degeneration of RGCs
in response to any consequence of the primary insult, such as
oxidative stress or release of intracellular glutamates reserves,
which can occur rapidly after onset of injury.1,33,61 An advantage
of the pONT model of RGC degeneration is that primary and
secondary degeneration are considered spatially segregated, with
approximately 75% of RGC loss in the superior retina but only 25%
of RGC loss in the inferior retina reported to be a result of primary
degeneration.19 In the present study, the half-life of RGCs in the
pONT model was substantially less in superior and central retinal
sectors versus the inferior, nasal and temporal retinal periphery,
suggesting greater primary degeneration indeed occurs in these
regions. A combination of primary and secondary degeneration
was found to occur in both superior and inferior sectors of the
pONT model in broad agreement with previous observations.19
However the observation that the central retina showed greater
proportion of RGC loss than the peripheral retina in this model was
unexpected and may be because the DA rat exhibit less ectopic
axonal organisation than other species.31 By comparison, reductions
in RGC density in the OHT model were mirrored by signiﬁcant
increases in mean NND. The change in distribution of normalised
NNDs suggested a similar combination of clustered and diffuse
RGC loss as observed in the pONT model, albeit to a lesser extent,
reﬂecting the less severe insult. To the authors’ knowledge, this
study presents the ﬁrst evidence to suggest primary and secondary
degenerative processes in the rat OHT model.
Contralateral eyes are frequently used as untreated controls
in animal models of glaucoma. This study reports that eyes
contralateral to those subject to short-term IOP elevation were
found to undergo signiﬁcant RGC loss versus naïve eyes, despite
exhibiting no signiﬁcant change in IOP (Table 1 and Figure 5). RGC
density loss in collateral eyes was less than that observed in eyes
subject to increased IOP, but nevertheless signiﬁcant compared
with controls (Table 1). RGC density loss was most pronounced in
the central retina (Figure 5). The pattern of RGC loss was different
to that observed in OHT eyes, in that the pattern was less well
deﬁned with greatest loss in the nasal–temporal sectors (Figure 6).
The surprising observation of RGC loss in contralateral eyes of rat
glaucoma models is not without precedence. For example, unilateral
optic nerve injury in the rat has previously been associated with
bilateral activation of the pro-apoptotic transcription factor c-jun in
RGCs, microglial activation and glia proliferation,62,63 and upregula-
tion of stress response factor βB2-crystallin;64 thought to play a role
in neuroprotection and axonal regeneration.65 In murine models,
contralateral upregulation of glial ﬁbrillary acid protein, major
histocompatibility complex-II (MHC-II) and the glial gap junction
protein connexion 43 are reported, in addition to RGC loss.66–68
Several explanations have been proposed to describe the origin of
the contralateral RGC degeneration observed in glaucoma models,
including secretion of pro-inﬂammatory cytokines into the circula-
tion, the propagation of degenerative signals from insulted to
contralateral eyes via the visual centres of the brain or as a systemic
autoimmune response.69 The present study supports a growing
body of evidence to suggest contralateral RGC loss in rodent models
of retinal degeneration, and presents data to suggest that different
patterns of RGC loss in OHT and contralateral eyes are observed in
the well-established rat OHT model of glaucoma.
In conclusion, this article describes a novel algorithm to
automatically extract information to a greater granularity than
has previously been achieved from Brn3a-labelled retinal whole-
mounts. We show how this technique can be successfully used to
investigate the extent and spatial segregation of primary and
secondary degenerative processes in models of neurodegenera-
tion. Furthermore, we demonstrate contralateral effects of OHT on
RGC populations.
MATERIALS AND METHODS
Animals
Adult male Dark Agouti rats (150–200 g) were treated with procedures
approved by the UK Home Ofﬁce and in compliance with the ARVO
Statement for the Use of Animals in Ophthalmic and Vision Research. All
animals (80 rats, 100 eyes) were maintained in a 12 h light (140–260 lux)–
12h dark cycle, with food and water ad libitum.
pONT model induction
pONT was performed in the left eye of 35 DA rats, using an adaptation of
a previously described technique.7,10 Brieﬂy, under general anaesthesia, an
incision was made in the superior conjunctiva, exposing the optic nerve
sheath. The optic nerve was then exposed using a longitudinal slit in the
dura mater to allow a 0.2 mm cut to be made in the dorsal optic nerve
2 mm behind the eye using an ophthalmic scalpel with a steel cutting
guard. Damage to major ophthalmic blood vessels was avoided and
veriﬁed at the end by ophthalmoscopy. Animals were killed 3, 7, 21 and
56 days post pONT surgery. A population of bilaterally untreated (naïve)
retinas were used as controls.
OHT model induction
OHT was surgically induced in the left eye of 25 DA rats as described
previously.42 IOP was elevated in the left eye of each animal by the
injection of 0.05 ml hypertonic saline solution (1.80 M) into the two
episcleral veins using a syringe pump (0.05 ml/min; UMP2; World Precision
Instruments, Sarasota, FL, USA). A propylene ring, with a 1-mm gap cut out
of its circumference, was placed around the equator to prevent injected
saline outﬂow from other aqueous veins.
The IOP of both eyes in each rat was measured at regular intervals with
a tonometer (TonoLab; Tiolat Oy, Heisinki, Finland) under inhalational
anaesthesia (0.4% isoﬂurane in oxygen). For each animal, cumulative IOP
exposure, deﬁned as the integral of IOP elevation over time (mm Hg/day),
was calculated from the area under the curve, as previously described.
Animals were killed 7, 21, 56 and 84 days post-surgery. A population of
bilaterally untreated (naïve) retinas were used as controls.
Brn3a immunohistochemistry and confocal microscopy
After animals were killed, both eyes were enucleated and ﬁxed in 4%
paraformaldehyde at 4 °C overnight before dissecting retinal whole-
mounts. Whole-mounts were stained for the RGC speciﬁc nuclear-localised
transcription factor Brn3a using an anti-mouse mAb (1:500; Merk Millipore,
Darmstadt, Germany) and examined under confocal microscopy (LSM 710;
Carl Zeiss MicroImaging GmbH, Jena, Germany). Each retinal whole-mount
was imaged as a tiled z-stack at × 10 magniﬁcation, which was used to
generate a single plane maximum projection of the RGC layer in each
retina for subsequent analysis (Figure 1a). Each whole-mount image was
manually orientated so that the superior retina was towards the top of the
image using in vivo cSLO imaging of retinal vasculature as a reference.
Retina image acquisition settings were kept constant for all retinas imaged,
allowing comparison of Brn3a expression in each experimental group as
previously described.50
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Automated quantiﬁcation of Brn3a-labelled RGCs in retinal
whole-mounts
Quantiﬁcation of Brn3a-labelled RGCs in retinal whole-mounts was
achieved using an algorithm previously described.10 Brieﬂy, a high-pass
ﬁlter was ﬁrst applied to the 8-bit Brn3a-labelled channel to remove
background followed by application of a 130 intensity threshold. The
ImageJ watershed algorithm was then used to separate touching particles
and those within 7–21 μm size range were counted based on RGC sizes
previously reported.34 Only particles with a circularity 40.7 were
considered to be RGCs. Once identiﬁed, a region of interest was deﬁned
for each RGC (Figure 1c) from which RGC area, mean grey pixel intensity
and centroid (x,y) were recorded. The NND was determined for each
RGC using an ImageJ macro developed by Yuxiong Mao (https://icme.hpc.
msstate.edu/mediawiki/index.php/Nearest_Neighbor_Distances_Calculatio
n_with_ImageJ) from which RI was calculated as described previously
(equation (1)), where x is the mean nearest neighbour distance and σ is the
standard deviation of nearest neighbour distance.70
RI ¼ xNND
σNND
ð1Þ
Whole-mount retinal area determination and segmentation
The area of each retina was determined by manually applying a low
intensity threshold (0–5) to each image to create a mask of retinal whole-
mount area (Figure 1b). Retinal area (black pixels) was measured using
ImageJ as described previously.10 To determine the area of segmented
retina, a series of 15 concentric rings of increasing radii (0.3 mm) centred
on the ONH were applied to the whole-retinal mask and the areas of each
subdomain were determined (Figure 1c). Rings were further subdivided
into quadrants (Figure 1d) using the centre of the ONH (a,b) as the retinal
centre in each case.
Automated Brn3a-labelled RGC retinal segmentation
Once identiﬁed, RGCs were further segmented into a series of 15
concentric rings of increasing radii (0.6 mm) centred on (a,b). This was
achieved by calculating the Euclidean distance of each RGC centroid
relative to the ONH centre using equation (2), where (x,y) is the centroid of
each RGC.
d ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðx - aÞ2 þ ðy - bÞ2
q
ð2Þ
For whole-ring retinal analysis the Euclidean distance [D] of each RGC was
used to gate cells into a series of 15 concentric rings 0.6 mm in radii
centred on the ONH. Rings were labelled 1 to 15 with ring 1 centred on the
ONH and 15 on the retinal peripheral (Figure 1c). For quadrant analysis
(Figures 1d and e), RGCs were gated into one of four quadrants: Temporal,
Superior, Inferior and Nasal using Cartesian or polar coordinate based
segmentation which gave identical results.
Mean RGC density was determined for each ring or by dividing the RGC
count in each sector by the corresponding retinal area. Mean NND for each
region was calculated by averaging NNDs for RGCs within each sector. In
each case RI was calculated from mean NND and σNND of each sector, as
described above. Colour mapped scatterplots were drawn for qualitative
analysis using RGC centroid and NND values with Origin 2015 (OriginLabs,
Northampton, MA, USA).
Determining the rate of RGC primary and secondary degeneration
To determine half-life of RGC loss in both models, longitudinal proﬁles of
RGC density in each retinal segment were ﬁt to a one-phase exponential
decay model with plateau (equation (3)) (Figure 6).
y ¼ Y0 Plateauð Þ ´ exp K ´ Xð Þ þ Plateau ð3Þ
To determine the percentage of primary degeneration in each retinal
segment, aforementioned RGC density proﬁles were ﬁt to a two-phase
exponential decay model with plateau (equations (4)–(6)). Results were
presented as colour maps (Figure 6c),
SF ¼ Y0- Plateauð Þ ´ PF ´ 0:01 ð4Þ
SS ¼ Y0 Plateauð Þ ´ 100 PFð Þ ´ 0:01 ð5Þ
y ¼ Plateauþ SFð Þ ´ exp KF ´ Xð Þ þ Plateauþ SSð Þ ´ exp KS ´ Xð Þ ð6Þ
where KF and Ks refer to the two rate constants ﬁxed using the fast
(primary degeneration) and slow (secondary degeneration) half-lives as
described in the text, SF and Ss refer to the span (distance between Y0 and
Plateau) accounted by the fast and slow components of the equation, and
PF is the percentage of primary degeneration.
Statistical analysis
All data were analysed with the Student’s t-test or one-way ANOVA with
Dunetts post hoc test versus control groups using GraphPad Prism 5
(GraphPad Software, Inc., La Jolla, CA, USA), unless described otherwise.
The longitudinal proﬁles of RGC degeneration following pONT and OHT
induction were ﬁtted with a one-phase and a two-phase exponential decay
model with plateau as described in the text. Data were presented as
means± S.E. and Po0.05 was considered signiﬁcant.
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